Modification of tumour growth with a defined glycoprotein antigen

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

MANY pathogens escape the body's immune system because their surface antigenic determinants elicit an immune response that is too weak, temporary, or of the wrong type. A plausible solution to this type of problem is to put the antigenic determinant specific for the pathogen on a suitable carrier and present it to the host immune system in a way that will elicit a protective immune response of the right type, time course, and strength. This has been called the "chemical vaccine" approach1.

Original languageEnglish (US)
Pages (from-to)99-101
Number of pages3
JournalNature
Volume244
Issue number5411
DOIs
StatePublished - Dec 1 1973

Fingerprint Dive into the research topics of 'Modification of tumour growth with a defined glycoprotein antigen'. Together they form a unique fingerprint.

  • Cite this